These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 12811256

  • 1. Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.
    Meijer E, Bloem AC, Dekker AW, Verdonck LF.
    Transplantation; 2003 Jun 15; 75(11):1910-3. PubMed ID: 12811256
    [Abstract] [Full Text] [Related]

  • 2. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
    Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D.
    Biol Blood Marrow Transplant; 2007 Mar 15; 13(3):299-306. PubMed ID: 17317583
    [Abstract] [Full Text] [Related]

  • 3. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y.
    Transplantation; 2003 Jun 27; 75(12):2135-43. PubMed ID: 12829926
    [Abstract] [Full Text] [Related]

  • 4. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jun 27; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 5. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.
    Duggan P, Booth K, Chaudhry A, Stewart D, Ruether JD, Glück S, Morris D, Brown CB, Herbut B, Coppes M, Anderson R, Wolff J, Egeler M, Desai S, Turner AR, Larratt L, Gyonyor E, Russell JA, Alberta Blood and Bone Marrow Transplant Program.
    Bone Marrow Transplant; 2002 Nov 27; 30(10):681-6. PubMed ID: 12420207
    [Abstract] [Full Text] [Related]

  • 6. Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors.
    Schattenberg A, van der Meer A, Preijers F, Schaap N, Rinkes M, van der Maazen R, Allebes W, Joosten I, De Witte T.
    Bone Marrow Transplant; 2004 Jun 27; 33(11):1115-21. PubMed ID: 15064694
    [Abstract] [Full Text] [Related]

  • 7. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug 27; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 8. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.
    Bone Marrow Transplant; 2005 Feb 27; 35(3):247-52. PubMed ID: 15580282
    [Abstract] [Full Text] [Related]

  • 9. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Sacchi N, van Lint MT, Bosi A, Gruppo Italiano Trapianti Midollo Osseo (GITMO).
    Biol Blood Marrow Transplant; 2006 May 27; 12(5):560-5. PubMed ID: 16635791
    [Abstract] [Full Text] [Related]

  • 10. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 27; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 11. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 27; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 12. Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation.
    Haraguchi K, Takahashi T, Hiruma K, Kanda Y, Tanaka Y, Ogawa S, Chiba S, Miura O, Sakamaki H, Hirai H.
    Bone Marrow Transplant; 2004 Oct 27; 34(7):595-602. PubMed ID: 15300228
    [Abstract] [Full Text] [Related]

  • 13. Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
    Elhasid R, Arush MB, Zaidman I, Leiba R, Barak AB, Postovsky S, Haddad N, Katz T, Pollack S, Sami I, Gidoni O, Rubin D, Mandel H, Attias D, Reisner Y, Etzioni A, Rowe JM.
    Biol Blood Marrow Transplant; 2007 Mar 27; 13(3):329-38. PubMed ID: 17317586
    [Abstract] [Full Text] [Related]

  • 14. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP, Gratama JW, Lamers C, van Esser JW, Bolhuis RL, Cornelissen JJ.
    Bone Marrow Transplant; 1999 May 27; 23(10):1013-7. PubMed ID: 10373067
    [Abstract] [Full Text] [Related]

  • 15. [Clinical trial of antithymocyte globulin for prophylaxis of acute graft-versus-host disease in pediatric recipients of bone marrow transplantation from unrelated donors].
    Yagasaki H, Kojima S, Inaba J, Kato K, Matsuyama T.
    Rinsho Ketsueki; 1999 May 27; 40(5):382-9. PubMed ID: 10390886
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F, Diyachenko G, Zabelina T, Wolschke C, Fehse B, Bacher U, Erttmann R, Kröger N, Zander AR.
    Biol Blood Marrow Transplant; 2008 Aug 27; 14(8):913-9. PubMed ID: 18640575
    [Abstract] [Full Text] [Related]

  • 17. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation.
    Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA.
    Bone Marrow Transplant; 1997 Jun 27; 19(11):1069-77. PubMed ID: 9193748
    [Abstract] [Full Text] [Related]

  • 18. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
    Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W.
    Ann Hematol; 2005 May 27; 84(5):331-8. PubMed ID: 15726363
    [Abstract] [Full Text] [Related]

  • 19. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 27; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 20. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK, Giver CR, Rosenthal H, Somani J, Langston AA, Lonial S, Roback JD, Li JM, Hossain MS, Redei I.
    Blood Cells Mol Dis; 2004 Feb 27; 33(3):233-7. PubMed ID: 15528137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.